Cg Oncology, Common Stock Price on March 28, 2024
| CGON Stock | 34.75 0.65 1.91% |
If you're considering investing in CGON Stock, it is important to understand the factors that can impact its price. As of today, the current price of CG Oncology, stands at 34.75, as last reported on the 30th of November, with the highest price reaching 34.85 and the lowest price hitting 33.95 during the day. As of now, CGON Stock is very steady. CG Oncology, Common retains Efficiency (Sharpe Ratio) of 0.0035, which signifies that the company had a 0.0035% return per unit of price deviation over the last 3 months. We have found twenty-four technical indicators for CG Oncology,, which you can use to evaluate the volatility of the firm. Please confirm CG Oncology,'s Market Risk Adjusted Performance of (0.02), variance of 7.53, and Information Ratio of (0.07) to double-check if the risk estimate we provide is consistent with the expected return of 0.0095%.
As of the 30th of November 2024, Stock Based Compensation To Revenue is likely to grow to 7.86, while Total Stockholder Equity is likely to drop about 128.4 M. . As of the 30th of November 2024, Price To Sales Ratio is likely to drop to 749.67. In addition to that, Price Earnings Ratio is likely to drop to -3.48. CGON Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
CGON |
Sharpe Ratio = 0.0035
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CGON |
Estimated Market Risk
| 2.74 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CG Oncology, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CG Oncology, by adding CG Oncology, to a well-diversified portfolio.
Price Book 4.2964 | Price Sales 3.4 K | Shares Float 45 M | Wall Street Target Price 66.625 | Earnings Share (15.87) |
Related Headline
NRG Energy Headline on 28th of March 2024
Disposition of 30 shares by Rasesh Patel of NRG Energy subje... by Rasesh Patel
Filed transaction by NRG Energy Officer: President, Nrg Consumer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
CG Oncology, Valuation on March 28, 2024
It is possible to determine the worth of CG Oncology, on a given historical date. On March 28, 2024 CGON was worth 40.96 at the beginning of the trading date compared to the closed value of 43.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CG Oncology, stock. Still, in general, we apply an absolute valuation method to find CG Oncology,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CG Oncology, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CG Oncology,'s related companies.
| Open | High | Low | Close | Volume | |
| 41.25 | 41.66 | 40.22 | 41.00 | 295,000 | |
03/28/2024 | 40.96 | 45.21 | 40.82 | 43.90 | 747,500 |
| 43.82 | 44.26 | 42.35 | 42.76 | 484,000 |
| Backtest CG Oncology, | | | CG Oncology, History | | | CG Oncology, Valuation | Previous | Next |
CG Oncology, Trading Date Momentum on March 28, 2024
| On April 01 2024 CG Oncology, Common was traded for 42.76 at the closing time. The top price for the day was 44.26 and the lowest listed price was 42.35 . The trading volume for the day was 484 K. The trading history from April 1, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.60% . The overall trading delta against the current closing price is 11.82% . |
CG Oncology, Common Fundamentals Correlations and Trends
By evaluating CG Oncology,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CG Oncology,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CGON financial account trend analysis is a perfect complement when working with valuation or volatility modules.About CG Oncology, Stock history
CG Oncology, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CGON is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CG Oncology, Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CG Oncology, stock prices may prove useful in developing a viable investing in CG Oncology,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.3 M | 4.1 M |
CG Oncology, Quarterly Net Working Capital |
|
CG Oncology, Stock Technical Analysis
CG Oncology, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
CG Oncology, Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
CG Oncology, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
CG Oncology, November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how CG Oncology, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CG Oncology, shares will generate the highest return on investment. By undertsting and applying CG Oncology, stock market strength indicators, traders can identify CG Oncology, Common entry and exit signals to maximize returns
CG Oncology, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CG Oncology,'s price direction in advance. Along with the technical and fundamental analysis of CGON Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CGON to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (0.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CG Oncology, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CG Oncology,. If investors know CGON will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CG Oncology, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (15.87) | Revenue Per Share 0.015 | Quarterly Revenue Growth 3.778 | Return On Assets (0.16) | Return On Equity (0.20) |
The market value of CG Oncology, Common is measured differently than its book value, which is the value of CGON that is recorded on the company's balance sheet. Investors also form their own opinion of CG Oncology,'s value that differs from its market value or its book value, called intrinsic value, which is CG Oncology,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CG Oncology,'s market value can be influenced by many factors that don't directly affect CG Oncology,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CG Oncology,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if CG Oncology, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CG Oncology,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.